ZIMMER BIOMET HOLDINGS, INC. Deferred Tax Expense from Stock Options Exercised
ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Deferred Tax Expense from Stock Options Exercised of $29.10 million for the 9-month period ending 2013-09-30, per its 10-Q filed 2013-11-12.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:DeferredTaxExpenseFromStockOptionsExercised · last filed 2013-11-12
- 2013-09-30: Deferred Tax Expense from Stock Options Exercised 9 month $29.10M.
- 2012-09-30: Deferred Tax Expense from Stock Options Exercised 9 month $10.00M.
| Period end | Deferred Tax Expense from Stock Options Exercised 9 month |
|---|---|
| 2013-09-30 | $29.10M 10-Q · filed 2013-11-12 |
| 2012-09-30 | $10.00M 10-Q · filed 2013-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |